Skip to content

AdaptHealth AHCO Amortization expense related to capitalized debt issuance costs

Amortization expense related to capitalized debt issuance costs at other companies

BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
Aveanna Healthcare Holdings Inc. logo
Aveanna Healthcare Holdings Inc.AVAH
The Pennant Group, Inc. logo
The Pennant Group, Inc.PNTG
Addus HomeCare logo
Addus HomeCareADUS
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
Savara logo
SavaraSVRA

Other financials

Income statement

See full
Revenue$819.8M+5.4%
Gross profit$111.5M-7.4%
Operating income$5.5M-76.3%
Net income-$16.0M-123%
EPS (diluted)-$0.12-140%

Balance sheet

See full
Cash & equivalents$48.0M-10.6%
Total debt$2.0B-4.9%
Total equity$1.5B-3.9%
Total assets$4.4B-0.3%

Cash flow

See full
Operating cash flow$93.7M-1.9%
CapEx$121.2M+26.8%
Free cash flow-$27.5M-47,297%

Valuation

See full
Market cap$1.36B+20.5%
Enterprise value$3.32B+4.3%
P/S0.4×+0.1×

Profitability

See full
Gross margin18.3%-1.6pp
Operating margin8%+6.9pp
Net margin-2.4%-5.1pp
FCF margin5.8%-2.6pp

Returns & leverage

See full
Return on equity-5.2%-10.8pp
Debt / equity1.3×0.0×
Current ratio0.9×-0.4×

Where this comes from

Reported directly by AdaptHealth in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCosts.

The official record: AdaptHealth’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about AdaptHealth's amortization expense related to capitalized debt issuance costs.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AdaptHealth's amortization expense related to capitalized debt issuance costs?
AdaptHealth (AHCO) reported amortization expense related to capitalized debt issuance costs of $1.19M in Q1 2026.
How has AdaptHealth's amortization expense related to capitalized debt issuance costs changed year-over-year?
AdaptHealth's amortization expense related to capitalized debt issuance costs decreased by 7.6% year-over-year, from $1.28M to $1.19M.
What is the long-term trend for AdaptHealth's amortization expense related to capitalized debt issuance costs?
Over 4 years (2021 to 2025), AdaptHealth's amortization expense related to capitalized debt issuance costs has grown at a 1.4% compound annual growth rate (CAGR), from $5.38M to $5.69M.